Insulet
PODD
#1049
Rank
โ‚น1.925 T
Marketcap
โ‚น27,354
Share price
-3.62%
Change (1 day)
20.72%
Change (1 year)
Categories
Insulet Corporation is an American company that develops and sells medical devices used for the administration of insulin.

Revenue for Insulet (PODD)

Revenue in 2025 (TTM): โ‚น218.27 Billion

According to Insulet's latest financial reports the company's current revenue (TTM ) is โ‚น226.55 Billion. In 2024 the company made a revenue of โ‚น177.71 Billion an increase over the revenue in the year 2023 that were of โ‚น141.28 Billion. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Insulet from 2006 to 2025

Annual revenue

Year Revenue Change
2025 (TTM) โ‚น218.27 B22.82%
2024 โ‚น177.71 B25.79%
2023 โ‚น141.28 B30.8%
2022 โ‚น108.01 B32.07%
2021 โ‚น81.78 B23.65%
2020 โ‚น66.14 B25.65%
2019 โ‚น52.64 B33.53%
2018 โ‚น39.42 B33.14%
2017 โ‚น29.61 B18.74%
2016 โ‚น24.93 B33.92%
2015 โ‚น18.62 B1.76%
2014 โ‚น18.29 B19.87%
2013 โ‚น15.26 B31.9%
2012 โ‚น11.57 B43.69%
2011 โ‚น8.05 B85.37%
2010 โ‚น4.34 B41.81%
2009 โ‚น3.06 B76.78%
2008 โ‚น1.73 B230.26%
2007 โ‚น0.52 B203.12%
2006 โ‚น0.17 B

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ICU Medical
ICUI
โ‚น208.45 B-7.99%๐Ÿ‡บ๐Ÿ‡ธ USA
Tandem Diabetes Care
TNDM
โ‚น90.46 B-60.07%๐Ÿ‡บ๐Ÿ‡ธ USA
DexCom
DXCM
โ‚น405.69 B 79.07%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
โ‚น8.278 T 3,553.95%๐Ÿ‡บ๐Ÿ‡ธ USA
Abbott Laboratories
ABT
โ‚น3.938 T 1,638.49%๐Ÿ‡บ๐Ÿ‡ธ USA
Medtronic
MDT
โ‚น3.072 T 1,256.12%๐Ÿ‡ฎ๐Ÿ‡ช Ireland
Eli Lilly
LLY
โ‚น5.338 T 2,256.15%๐Ÿ‡บ๐Ÿ‡ธ USA